Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
HES
Hess
HES
|
+$1.28B |
| 2 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$1.02B |
| 3 |
Bank of America
BAC
|
+$770M |
| 4 |
Gilead Sciences
GILD
|
+$378M |
| 5 |
Chipotle Mexican Grill
CMG
|
+$346M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.78B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$973M |
| 3 |
Walt Disney
DIS
|
+$588M |
| 4 |
Eli Lilly
LLY
|
+$569M |
| 5 |
AT&T
T
|
+$529M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 3.4% |
| 2 | Healthcare | 3.08% |
| 3 | Financials | 2.41% |
| 4 | Consumer Discretionary | 2.33% |
| 5 | Industrials | 1.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
10351
PUT
Funko
FNKO
$344M
| $185K | ﹤0.01% |
29,700
+600
| +2% | +$4.21K |
|
|
KALV
10352
CALL
DELISTED
KalVista Pharmaceuticals
KALV
| $185K | ﹤0.01% |
15,600
-34,500
| -69% | -$460K |
|
10353
Stereotaxis
STXS
$138M
| $185K | ﹤0.01% |
70,884
-52,139
| -42% | -$124K |
|
10354
Kaltura
KLTR
$249M
| $185K | ﹤0.01% |
136,846
+13,865
| +11% | +$21.5K |
|
10355
CALL
iShares Global REIT ETF
REET
$5.09B
| $185K | ﹤0.01% |
7,800
+1,700
| +28% | +$39.8K |
|
|
PETQ
10356
CALL
DELISTED
PetIQ, Inc. Class A Common Stock
PETQ
| $185K | ﹤0.01% |
10,100
-1,200
| -11% | -$21.4K |
|
10357
CALL
Relmada Therapeutics
RLMD
$512M
| $185K | ﹤0.01% |
39,700
+13,000
| +49% | +$62.6K |
|
10358
Flux Power
FLUX
$12.7M
| $184K | ﹤0.01% |
41,562
+20,110
| +94% | +$93.3K |
|
10359
PUT
Treace Medical Concepts
TMCI
$312M
| $184K | ﹤0.01% |
14,100
-11,800
| -46% | -$157K |
|
10360
PUT
Hain Celestial
HAIN
$52.4M
| $184K | ﹤0.01% |
23,400
-21,200
| -48% | -$209K |
|
10361
PUT
Westrock Coffee
WEST
$823M
| $184K | ﹤0.01% |
17,800
+15,600
| +709% | +$157K |
|
10362
CALL
Betterware México
BWMX
$613M
| $184K | ﹤0.01% |
9,200
+700
| +8% | +$10.8K |
|
10363
PUT
State Street SPDR Bloomberg 1-3 Month T-Bill ETF
BIL
$46.7B
| $184K | ﹤0.01% |
2,000
-2,000
| -50% | -$183K |
|
10364
PUT
MiMedx Group
MDXG
$622M
| $183K | ﹤0.01% |
23,800
+5,500
| +30% | +$44.2K |
|
10365
Quantum-Si Incorporated
QSI
$162M
| $183K | ﹤0.01% |
93,000
-32,130
| -26% | -$56.1K |
|
|
SILK
10366
PUT
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
| $183K | ﹤0.01% |
10,000
-1,800
| -15% | -$28.6K |
|
|
AVNS
10367
PUT
DELISTED
Avanos Medical
AVNS
| $183K | ﹤0.01% |
9,200
+4,200
| +84% | +$81.2K |
|
10368
PUT
Mirion Technologies
MIR
$3.96B
| $183K | ﹤0.01% |
16,100
-2,300
| -13% | -$23K |
|
10369
PUT
Rayonier
RYN
$6.49B
| $183K | ﹤0.01% |
6,062
-551
| -8% | -$16.5K |
|
10370
Global X Genomics & Biotechnology ETF
GNOM
$85.4M
| $183K | ﹤0.01% |
+4,016
| New | +$183K |
|
10371
State Street SPDR Nuveen ICE High Yield Municipal Bond ETF
HYMB
$3.36B
| $183K | ﹤0.01% |
7,112
-70,187
| -91% | -$1.78M |
|
10372
GCM Grosvenor
GCMG
$2.81B
| $183K | ﹤0.01% |
18,909
-53,262
| -74% | -$463K |
|
10373
VOC Energy
VOC
$53.9M
| $183K | ﹤0.01% |
30,190
+28,752
| +1,999% | +$193K |
|
10374
CALL
VanEck Merk Gold Trust
OUNZ
$2.71B
| $183K | ﹤0.01% |
8,500
-11,100
| -57% | -$222K |
|
10375
Westwood Holdings Group
WHG
$186M
| $183K | ﹤0.01% |
14,816
-11,445
| -44% | -$138K |
|
Similar funds
Citadel Advisors's Q1 2024 Portfolio in Review
As of Q1 2024, Citadel Advisors held 15,912 positions worth $518B, up 3.6% from $500B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Citadel Advisors withdrew a net $36B in Q1 2024, closing 1,439 positions and reducing 6,148 holdings. Its most notable exit was iShares National Muni Bond ETF, an estimated $183M position sold in full.
By sector, the portfolio is most concentrated in Technology at 3.4% of assets, down from 3.8% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Citadel Advisors opened a new position in TD Synnex worth $245M.
- Citadel Advisors's largest Q1 2024 buy was TD Synnex: 2,162,840 shares worth $245M.
- Citadel Advisors added most to Hess in Q1 2024, an estimated $1.28B increase.
- Citadel Advisors's biggest Q1 2024 reduction was NVIDIA, cutting an estimated $1.78B.
- Citadel Advisors fully exited iShares National Muni Bond ETF in Q1 2024, selling an estimated $183M.
- Citadel Advisors's ten largest holdings make up 30% of its $518B portfolio in Q1 2024.
- Citadel Advisors opened 1,749 new positions and closed 1,439 in Q1 2024.
- Citadel Advisors's portfolio value rose 3.6% quarter-over-quarter to $518B.
Based on Citadel Advisors's 13F filing for Q1 2024, filed 15 May 2024.